169 related articles for article (PubMed ID: 18559727)
1. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.
Lee WT; Tamai H; Cohen P; Teker AM; Shu S
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):608-13. PubMed ID: 18559727
[TBL] [Abstract][Full Text] [Related]
2. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice.
Mandpe AH; Tsung K; Norton JA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):786-92. PubMed ID: 12874083
[TBL] [Abstract][Full Text] [Related]
3. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
Jeong HS; Lee H; Ko Y; Son YI
Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids.
Lee WT; Tan C; Koski G; Shu S; Cohen P
Head Neck; 2010 Sep; 32(9):1209-16. PubMed ID: 20054852
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells pulsed with apoptotic squamous cell carcinoma have anti-tumor effects when combined with interleukin-2.
Son YI; Mailliard RB; Watkins SC; Lotze MT
Laryngoscope; 2001 Aug; 111(8):1472-8. PubMed ID: 11568586
[TBL] [Abstract][Full Text] [Related]
6. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
Yasuda T; Kamigaki T; Kawasaki K; Nakamura T; Yamamoto M; Kanemitsu K; Takase S; Kuroda D; Kim Y; Ajiki T; Kuroda Y
Cancer Immunol Immunother; 2007 Jul; 56(7):1025-36. PubMed ID: 17131118
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with dendritic cells in an animal model of early pulmonary metastatic squamous cell carcinoma.
Moon JH; Chung MK; Son YI
Laryngoscope; 2012 Nov; 122(11):2442-6. PubMed ID: 22926978
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
9. Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII).
Khariwala SS; Kjaergaard J; Lorenz R; Van Lente F; Shu S; Strome M
Laryngoscope; 2006 May; 116(5):814-20. PubMed ID: 16652094
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines.
Cho EI; Tan C; Koski GK; Cohen PA; Shu S; Lee WT
Head Neck; 2010 Jun; 32(6):700-7. PubMed ID: 19908319
[TBL] [Abstract][Full Text] [Related]
11. Tumor-dendritic cell fusion as a basis for cancer immunotherapy.
Lee WT; Shimizu K; Kuriyama H; Tanaka H; Kjaergaard J; Shu S
Otolaryngol Head Neck Surg; 2005 May; 132(5):755-64. PubMed ID: 15886631
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
Tamai H; Watanabe S; Zheng R; Deguchi K; Cohen PA; Koski GK; Shu S
Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
[TBL] [Abstract][Full Text] [Related]
13. Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells.
O-Sullivan I; Ng LK; Martinez DM; Kim TS; Chopra A; Cohen EP
Cancer Gene Ther; 2005 Oct; 12(10):825-34. PubMed ID: 15891775
[TBL] [Abstract][Full Text] [Related]
14. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
[TBL] [Abstract][Full Text] [Related]
15. Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma.
Matsunaga A; Ueda Y; Yamada S; Harada Y; Shimada H; Hasegawa M; Tsujii H; Ochiai T; Yonemitsu Y
Cancer; 2010 Aug; 116(15):3740-8. PubMed ID: 20564091
[TBL] [Abstract][Full Text] [Related]
16. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
17. Hybrid-primed lymphocytes and hybrid vaccination prevent tumor growth of lewis lung carcinoma in mice.
Savai R; Schermuly RT; Schneider M; Pullamsetti SS; Grimminger F; Seeger W; Banat GA
J Immunother; 2006; 29(2):175-87. PubMed ID: 16531818
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.
Kuriyama H; Watanabe S; Kjaergaard J; Tamai H; Zheng R; Weinberg AD; Hu HM; Cohen PA; Plautz GE; Shu S
Cell Immunol; 2006 Sep; 243(1):30-40. PubMed ID: 17207783
[TBL] [Abstract][Full Text] [Related]
20. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]